FDA Says Studies By Panexcell And Synchron “Unacceptable”
US Agency Warns Pharmaceutical Companies Against Using Firms’ Data
• By Akriti Seth
After conducting inspections at the facilities of Panexcell and Synchron, FDA finds data integrity issues • Source: Alamy 
